Innospec Inc. (IOSP) Stock Price & How to Invest
Last updated November 2026
Short answer
Innospec (NASDAQ: IOSP) is a mid-cap specialty chemicals maker selling fuel additives, personal and home care ingredients, and oilfield chemicals, and it trades as a debt-free, moderately valued industrial name at about ~20 times trailing earnings and ~16 times forward estimates after all three of its segments returned to growth in the first half of 2026. As of October 16, 2026 the shares closed near ~$97, up ~27% year to date and ~31% over one year, for a market value of about ~$2.4 billion.
IOSP stock price
As of 2026-11-16, Innospec Inc. (IOSP) last closed at $79.17, up 9.6% over the past year. Over the past 52 weeks it has traded between $65.89 and $101.41.
Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Innospec Inc.'s investor relations page. Walnut is informational, not investment advice.
IOSP key stats
At $79.17 on November 16, 2026, Innospec Inc. (IOSP) has a market cap of $1.9B, a P/E of 14.0 on trailing earnings (13.3 on forward earnings) and a dividend yield of 2.37%.
- Market cap
- $1.9B
- P/E (trailing)
- 14.0
- P/E (forward)
- 13.3
- EPS (trailing 12 months)
- $5.66
- Price to book
- 1.4
- Dividend yield
- 2.37%
- Beta
- 0.85
Market cap, P/E and yield are measured at the $79.17 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.
What's new with Innospec Inc. (IOSP)?
The last two weeks for Innospec Inc., as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.
- IOSP closed at $79.17 on November 16, 2026, down 1.3% over the past five trading days (from $80.21).
- On November 4, 2026, Innospec Inc. filed its quarterly report (10-Q) with the SEC. Read the 10-Q on sec.gov
- On November 3, 2026, Innospec Inc. filed an 8-K with the SEC reporting quarterly results and information shared with investors (Regulation FD) (Item 2.02, Item 7.01). Read the 8-K on sec.gov
Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.
Innospec Inc. (IOSP) latest quarter
Innospec reported revenue of $474 million for Q3 2026, up 7% from a year earlier (Innospec, Nov 3, 2026).
Source: Innospec Q3 2026 results, Nov 3, 2026. Full earnings breakdown
What does Innospec Inc. (IOSP) do?
Innospec Inc. is an Englewood, Colorado specialty chemicals company that listed in 1998 as Octel Corp and took the Innospec name in 2006. It reports three segments. Fuel Specialties, the profit engine, sells combustion improvers, detergents, cold flow additives and stabilizers to refiners, fuel marketers and the aviation gasoline market, and produced ~$185.7 million of revenue at a ~36.6 percent gross margin in the second quarter of 2026. Performance Chemicals supplies surfactants and formulation ingredients for personal care, home care and industrial customers, contributing ~$190.3 million at a much thinner ~17.3 percent gross margin. Oilfield Services sells production and completion chemicals plus drag reducing agents, which let pipeline operators push more volume through existing lines, and added ~$115.4 million. About ~2,450 employees serve customers across the Americas, EMEA and Asia Pacific.
The second quarter of 2026 was the cleanest print Innospec has delivered in some time. Revenue of ~$491.4 million rose ~12 percent, operating income climbed ~16 percent to ~$39.7 million, every segment grew, and adjusted EPS of ~$1.27 beat the ~$1.05 analyst consensus. The stock has responded: it closed near ~$97 on October 16, 2026, up ~15 percent over three months and ~27 percent in 2026, close to its 52-week high of about ~$100. Third-quarter results are scheduled for November 3, 2026, with consensus near ~$1.26 of EPS on ~$479 million of revenue. The balance sheet is the standout: no drawn debt, ~$250.2 million of cash, and an undrawn ~$250 million revolving facility running to 2028, which funds a semi-annual dividend of ~92 cents per share, a ~$75 million buyback authorized in May 2026, and bolt-on acquisitions. Set against that is the quality of the growth. Adjusted EBITDA of ~$50.1 million was only marginally ahead of last year, adjusted EPS of ~$1.27 was essentially flat, and a good share of the revenue gain came from price, mix and currency rather than volume. Cash conversion has been poor so far in 2026, with ~$24.8 million of first-half operating cash flow against ~$31.7 million of capital and software spending, largely because receivables built by ~$70.2 million.
What's driving Innospec Inc. (IOSP)?
1. Fuel Specialties carries the earnings
Fuel Specialties supplied roughly ~38 percent of second-quarter revenue but close to ~59 percent of pre-corporate segment operating income, at a ~36.6 percent gross margin. Management describes a broad set of regional and end-market openings across traditional fuel, renewable fuel and non-fuel applications, and the segment has been the most consistent of the three. Approvals, formulation know-how and long qualification cycles make this end of the business hard to displace.
2. Oilfield Services rebuilding on drag reducing agents
This segment fell ~29 percent in 2024 when Latin America production activity dried up, and it is the piece now recovering fastest. Second-quarter revenue rose ~14 percent to ~$115.4 million, gross margin improved ~2.7 points to ~32.3 percent, and operating income jumped ~40 percent to ~$8.7 million, driven by a recent drag reducing agent plant expansion. Management has pointed to further sequential improvement in the second half, plus growth in US and Middle East completions and production chemicals.
3. Performance Chemicals margin repair
Performance Chemicals is the largest segment by revenue and the thinnest by margin, at ~17.3 percent gross. Operating income still rose ~15 percent to ~$16.4 million on price and mix of ~8 percent, even with volumes down ~2 percent. A North Carolina plant is still working through repairs, process improvements and upgrades after severe first-quarter weather, which held back production volumes and created negative manufacturing variances, so returning that site to normal run rates is the clearest near-term swing factor.
4. Balance sheet optionality and capital returns
Innospec closed the quarter with ~$250.2 million of cash, no drawn debt, and a ~$250 million revolver undrawn to May 2028, a rare position among chemicals companies. That supports a dividend costing ~$1.84 per share annually at a payout ratio near ~37 percent, a ~$75 million three-year repurchase authorization begun in May 2026 (~$6.4 million used in the quarter), and capacity for acquisitions such as the QGP deal inside Performance Chemicals. The offset is that first-half free cash flow was negative on working capital, so the cash pile did shrink from ~$292.5 million at year end.
What are the risks to Innospec Inc. (IOSP)?
Performance Chemicals runs at roughly a ~17 percent gross margin, so modest moves in raw material cost or personal care demand swing a disproportionate amount of operating income, and the North Carolina site has not yet returned to normal production. Fuel Specialties gross margin slipped ~1.5 points year over year on an adverse Americas sales mix, and its AvGas line saw volumes fall ~21 percent, a business tied to leaded aviation gasoline where the long-run regulatory direction points toward unleaded alternatives. Both Fuel Specialties and Oilfield Services recorded adverse movements in doubtful-debt provisions during the quarter, which deserves attention given how concentrated Oilfield Services is in the Americas. Most of the revenue and cost base sits outside the United States, so reported results carry real currency translation noise and the ~2 to ~3 point currency tailwind in the second quarter can reverse. Innospec also continues to disclose a misappropriation of inventory in Brazil first reported in its 2023 annual report, against which it has lodged civil and criminal claims with no offsetting recovery asset recorded and no significant developments since. After a ~27 percent rise in 2026 the shares sit near the top of their 52-week range, so the valuation now leaves less room for a soft quarter, and analysts expect full-year 2026 EPS of ~$4.92, roughly flat on the trailing figure, before a rebound to ~$6.17 in 2027.
What is the Innospec Inc. (IOSP) forecast?
3 analysts publish price targets on IOSP, averaging $99.33 as of November 2026, or +25.5% against the $79.17 share price on November 16, 2026. The published targets run from $93.00 to $110.00, a narrow spread, and the ratings split 3 buy, 0 hold, 0 sell. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.
Read the full IOSP forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.
Is IOSP a buy or a sell?
We give no verdict on Innospec Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.
The case for buying. Fuel Specialties carries the earnings. Fuel Specialties supplied roughly ~38 percent of second-quarter revenue but close to ~59 percent of pre-corporate segment operating income, at a ~36.6 percent gross margin. The most optimistic published target, $110.00, assumes this works close to its best case.
The case against. Performance Chemicals runs at roughly a ~17 percent gross margin, so modest moves in raw material cost or personal care demand swing a disproportionate amount of operating income, and the North Carolina site has not yet returned to normal production. The most pessimistic target, $93.00, is roughly what IOSP is worth if this bites instead.
Read the full bull and bear case on IOSP, including what would have to change to break either one. Walnut is not an investment adviser.
Has Innospec Inc. (IOSP) split its stock?
No. Innospec Inc. (IOSP) has not split its stock in the last 10 years. The statement covers only the window we check, so an older split in the company’s history is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.
How is Innospec Inc. (IOSP) valued?
Market cap, P/E and dividend yield at today's price are in the IOSP key stats above. The business figures below come from Innospec Inc.'s reported results as of October 2026 and change when it next reports.
- Revenue (TTM): ~$1.84 billion, with Q2 2026 revenue of ~$491.4 million, up ~12% year over year
- Net income (TTM): ~$122 million
- Operating and net margin: ~8.1% operating, ~6.6% net on a trailing basis; ~27.5% gross
- Net cash and dividend: ~$250 million cash, ~$48 million debt (mostly leases); ~$1.79 trailing dividend, a yield near ~1.85%
As of October 2026: At roughly ~$97 a share on October 16, 2026 and a market cap near ~$2.39 billion, Innospec trades at about ~20 times trailing earnings, ~16 times 2027 consensus EPS of ~$6.17 and ~1.3 times sales, with enterprise value pulled lower by the net cash position. The three analysts tracked have a mean target of ~$101, only a few percent above the current price after the 2026 rally. Trailing growth rates flatter the picture because the comparison base includes a ~$155.6 million non-cash settlement charge taken in 2024 when the company bought out its UK pension scheme, cutting that year's net income to ~$35.6 million against ~$139.1 million in 2023. Return on equity near ~9 percent and return on invested capital near ~11 percent read as solid rather than exceptional, which is roughly where the multiple sits.
Who competes with Innospec Inc. (IOSP)?
Fuel additives
Fuel Specialties competes with NewMarket's Afton Chemical, Infineum (the ExxonMobil and Shell joint venture), Lubrizol (owned by Berkshire Hathaway), Chevron Oronite and BASF. The market is concentrated and technical, where refiner approvals and multi-year qualification cycles matter more than raw scale, which helps explain gross margins holding in the mid-30s.
Personal and home care ingredients
Performance Chemicals sits against Croda, Clariant, Evonik, Stepan, Ashland and Syensqo. This end of specialty chemicals is closer to commodity surfactant economics and more exposed to consumer volumes and destocking cycles, and Innospec's ~17.3 percent gross margin there reflects the competitive reality.
Oilfield and pipeline chemicals
Oilfield Services runs into ChampionX (now inside SLB), Halliburton's Multi-Chem unit and Baker Hughes, and in drag reducing agents specifically against Berkshire's LiquidPower Specialty Products and NOV's Flowchem. Demand follows drilling, completion and pipeline throughput, making this the most cyclical of Innospec's three segments.
What stocks are similar to Innospec Inc. (IOSP)?
Other names that sit close to IOSP: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.
How to invest in Innospec Inc. (IOSP)
There are three common ways to get IOSP exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so IOSP sits alongside other stocks that express the same thesis.
Walnut takes the portfolio route. Describe a thesis where IOSP fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.
New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.
The bottom line on Innospec Inc. (IOSP)
IOSP pairs an unusually clean balance sheet and a high-margin fuel additives franchise with a thin-margin personal care business and lumpy oilfield demand, which is why it trades nearer a diversified industrial multiple than a premium specialty ingredients one.
More on Innospec Inc. (IOSP)
Whether IOSP is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is IOSP a buy or a sell?, and where the stock could go from here in the IOSP stock forecast.
For income investors, whether IOSP pays a dividend and how the payout looks is covered in does IOSP pay a dividend? And to weigh IOSP against a peer, read the full side-by-side comparisons: IOSP vs NEU and IOSP vs SHEL.
Wondering how IOSP fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Innospec Inc.
Ask Walnut's AI anything about IOSP and see how it fits what you own.
FAQ
What does Innospec do?
+
Innospec is a specialty chemicals company organized into three segments: Fuel Specialties (additives for refiners, fuel marketers and aviation gasoline), Performance Chemicals (surfactants and ingredients for personal care, home care and industrial uses), and Oilfield Services (production and completion chemicals plus drag reducing agents). Trailing revenue is about ~$1.84 billion.
Is Innospec profitable?
+
Yes. Innospec earned ~$30.8 million, or ~$1.25 per diluted share, in the second quarter of 2026, and about ~$122 million on a trailing twelve month basis. Trailing operating margin is roughly ~8.1 percent and net margin roughly ~6.6 percent, with first-half 2026 net income of ~$62.0 million against ~$57.5 million a year earlier.
Does Innospec pay a dividend?
+
It pays semi-annually rather than quarterly. The most recent payment was ~92 cents per common share, which annualizes to roughly ~$1.84; on trailing payments of ~$1.79 the yield is near ~1.85 percent at a share price around ~$97 in mid-October 2026. The payout ratio sits near ~37 percent of trailing earnings, and the company also repurchased ~$6.4 million of stock in the second quarter.
How much debt does Innospec carry?
+
Effectively none. The company had not drawn on its ~$250 million multicurrency revolving credit facility as of June 30, 2026, and held ~$250.2 million in cash and equivalents. Total reported debt of roughly ~$48 million is mostly leases, leaving a net cash position of about ~$202 million to ~$250 million depending on the measure used.
Which Innospec segment earns the most?
+
Fuel Specialties. In the second quarter of 2026 it produced ~$36.3 million of the ~$61.4 million in combined segment operating income on ~$185.7 million of revenue, at a ~36.6 percent gross margin. Performance Chemicals contributed ~$16.4 million and Oilfield Services ~$8.7 million, before ~$21.6 million of corporate costs.
Why did Innospec's 2024 net income fall so sharply?
+
The drop was mostly non-cash and non-operating. Innospec bought out its UK defined benefit pension scheme in 2024 and booked a settlement charge of about ~$155.6 million, roughly ~$4.65 per share, which cut reported net income to ~$35.6 million from ~$139.1 million in 2023. A ~29 percent revenue decline in Oilfield Services on weaker Latin America production activity compounded the year.
What is a drag reducing agent, and why does it matter for IOSP?
+
A drag reducing agent is a polymer injected into a pipeline that suppresses turbulence, letting an operator move more liquid through the same pipe without new capital. Innospec expanded its DRA production capacity recently, and management credits that expansion for the Oilfield Services rebound: revenue up ~14 percent and operating income up ~40 percent year over year in the second quarter.
What are the main risks in the Innospec story?
+
Thin Performance Chemicals margins near ~17 percent, an unfinished North Carolina plant repair, declining AvGas volumes down ~21 percent in the quarter against a long-term shift away from leaded aviation fuel, heavy non-US currency exposure, weak first-half cash conversion driven by a ~$70.2 million receivables build, and rising doubtful-debt provisions in two segments.
How did Innospec do in its latest quarter?
+
In the second quarter of 2026 Innospec reported revenue of ~$491.4 million, up ~12 percent from a year earlier, and adjusted EPS of ~$1.27, ahead of the ~$1.05 consensus, with all three segments growing. GAAP net income was ~$30.8 million. The third-quarter report is scheduled for November 3, 2026, with analysts looking for ~$1.26 of EPS on ~$479 million of revenue.
How has IOSP stock performed in 2026?
+
As of October 16, 2026, IOSP closed near ~$97, up about ~27 percent year to date, ~15 percent over three months and ~31 percent over one year, close to the top of its 52-week range of roughly ~$66 to ~$100. Past performance does not predict future returns.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Innospec Inc.'s investor relations page or your broker before making investment decisions.